Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth
Casual dining used to be a tough place to make money. Then Kevin Hochman took over Brinker Internati…
247wallst.com
HCP(HCP)
HCP
Signal
Leaning Bullish1↑1!
PRICE
Prev Close
34.78
Open
34.81
Day Range34.78 – 34.81
34.78
34.81
52W Range23.00 – 34.85
23.00
34.85
99% of range
VOLUME & SIZE
Avg Volume
3.2M
FUNDAMENTALS
P/E Ratio
-58.0x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +16% YoY · 81% gross marginValuation
FAIR
P/E not availableHealth
MODERATE
CR 3.5 · FCF negativeBullish
Key MetricsTTM
Market Cap$7.11B
Revenue TTM$654.89M
Net Income TTM-$122.22M
Free Cash Flow$64.59M
Gross Margin81.4%
Net Margin-32.7%
Operating Margin-43.6%
Return on Equity-15.8%
Return on Assets-11.3%
Debt / Equity0.01
Current Ratio3.50
EPS TTM$-0.98
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
3 strong3 concern
50/100Liquidity
3.50Strong
Leverage
0.01Strong
Coverage
0.0xConcern
ROE
-15.8%Concern
ROIC
-20.3%Concern
Cash
$763MStrong
ANALYST COVERAGE31 analysts
HOLD
▲ +3.5%upside to target
L $31.00
Med $36.00consensus
H $54.00Stock Health
Composite Score
2 of 4 signals bullish
8/10
Technicals
●
~RSI RangeRSI 71 — Overbought, caution
Fundamentals
●
✓Last EarningsBeat estimates
●
~Analyst ConsensusHold
●
✓LiquidityCurrent Ratio 3.50 — healthy liquidity
1 signal unavailable — limited data for this stock
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentOct 29, 2026
In 179 days
FinancialsFull statements →
Technicals
Technical SetupBULLISH
Technicals →Trend
▲ UptrendGolden Cross · 50D leads 200D by 1.3%
+1.5% vs SMA 50 · +2.8% vs SMA 200
Momentum
RSI70.8Overbought — pullback risk
MACD+0.00Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$34.84+0.2%
EMA 50
$34.78+0.0%
Current
$34.78
EMA 200
$32.35-7.0%
52W Low
$23.00-33.9%
52-Week RangeNear 52-week high
$23.0099th %ile$34.84
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 8 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2024 | $627.6M $627.6M–$627.6M | — | -$0.75 | — | — | Low2 |
FY2025 | $675.9M $674.3M–$678.9M | ▲ +7.7% | $0.35 | — | ±8% | High5 |
FY2026(current) | $774.1M $764.5M–$783.4M | ▲ +14.5% | $0.48 | ▲ +36.5% | ±38% | High8 |
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 8 consecutive quarters
Earnings HistoryHCP
Last 8Q
+450.8%avg beat
Beat 8 of 8 quarters↑ Estimates rising+68%
Q1'23
+50%
Q2'23
+33%
Q3'23
+168%
Q4'23
+267%
Q1'24
+641%
Q2'24
+2219%
Q3'24
+160%
Q4'24
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightAnalyst Activity
All ratings →No recent activity
JMP SecuritiesPerform → Market Perform
Jun 6
DOWNGRADE
JMP SecuritiesMarket Outperform → Perform
Jun 6
DOWNGRADE
Morgan StanleyOverweight → Equal-Weight
Apr 29
DOWNGRADE
ScotiabankSector Outperform → Sector Perform
Apr 25
DOWNGRADE
William BlairMarket Perform
Apr 24
DOWNGRADE
ScotiabankSector Outperform
Mar 12
UPGRADE
Morgan StanleyEqual-Weight → Overweight
Feb 26
UPGRADE
Cowen & Co.Outperform → Market Perform
Dec 8
DOWNGRADE
NeedhamHold → Buy
Mar 6
UPGRADE
Financials
INSTITUTIONAL OWNERSHIP
1
CAXTON ASSOCIATES LP
1.1M▲2
GGV Capital LLC
659K—3
Nuveen Asset Management, LLC
574K▼4
CIGOGNE MANAGEMENT SA
204K▲5
EDBI Pte Ltd
7K—6
Eisler Capital (UK) Ltd.
236K▲7
Eisler Capital (US) LLC
94K▲8
Flow State Investments, L.P.
30K▲News & Activity
HCP News
20 articles · 4h ago
Jobs Report, Palantir, Pinterest, AMD, PayPal, Disney, and More to Watch This Week
barrons.com
Should You Dump Bitcoin for Stocks After the S&P 500 Hit a New Record on Apple's $100 Billion Buyback?
247wallst.com
Nostalgia Powers Big Debut for ‘The Devil Wears Prada 2'
wsj.com
Greg Abel earns solid scorecard from Berkshire shareholders after first annual meeting
cnbc.com
Belgian pharma group UCB to buy Candid Therapeutics for up to $2.2 billion
reuters.com
Why FormFactor Stock Plummeted This Week
fool.com
Why Poet Technologies Stock Crashed This Week
fool.com
This Often Underappreciated Growth Stock Is Holding Its Own Against Giants Amazon and Alphabet. Time to Buy?
fool.com
Buy These 3 Dividend Stocks Today and Thank Yourself in 20 Years
fool.com
This Overlooked Precious Metals ETF Offers a 7% Yield
247wallst.com
Bronstein, Gewirtz & Grossman LLC Urges Grocery Outlet Holding Corp. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges zSpace, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges monday.com Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Eos Energy Enterprises, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Trip.com Group Limited Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Alight, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges ODDITY Tech Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
About
No description available.
Gurpreet SinghSenior Vice President of Networking
Susan LedgerPresident of Worldwide Field Operations & Director